AlphAIAlphAI — Financial news for AI agents
quantumcomputingreport.comAUG 13 min read$TWOH

Two Hands Corporation Begins External Beta Testing for EntangleX Quantum Simulator

Two Hands Corporation (OTC: TWOH), changing its name to Quantum X Inc., said it has begun external beta testing for EntangleX, a browser-based, GPU-accelerated classical quantum circuit simulator. The beta will be run with selected partners to assess usability, workflow, results display, and stability, with cloud and on-prem options. Further enhancements are planned later in 2026.

Original reporting
quantumcomputingreport.com
Published Aug 1, 2026, 12:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 1, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Two Hands Corporation Begins External Beta Testing for EntangleX Quantum Simulator — source image
Source · quantumcomputingreport.com
Decision brief

The 30-second read

$TWOHNeutralLow
01

Why it matters

The announcement is a product development milestone that could improve credibility with partners, but it does not provide financial metrics or adoption proof.

02

Market read

Traders may view this as incremental progress toward a software release, but the lack of commercial terms limits immediate trading impact.

03

What to watch

Beta success criteria (usability, stability) are qualitative, and the OTC micro-cap’s liquidity and execution risk could dominate any sentiment effect.

Relevance 4/10Novelty 5/10Timing: external beta phase begins now, with enhancements expected later in 2026

Background

Two Hands Corporation is reportedly changing its corporate identity to Quantum X Inc. and has been developing EntangleX internally.

Company-level read

Ticker impact

$TWOHNeutralMedium confidence
Context

Two Hands Corporation says EntangleX’s base UI is open to selected external partners for third-party beta testing, signaling product progress.

Expected impact

Near-term impact likely limited unless beta feedback leads to measurable adoption or a dated commercial release.

Evidence & confidence

The article discloses a new phase (external beta) and feature scope, but provides no revenue, pricing, or signed customer commitments.

Market effects

Sector

Adds incremental signal for classical quantum simulation tooling, but no clear read-through to public peers is provided.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because EntangleX is classical simulation and the article gives no commercial release date or contracts, the beta may not translate into near-term monetization.

Key entities

  • company
    Two Hands Corporation

    OTC-listed firm developing EntangleX and initiating external beta testing.

  • product
    EntangleX

    Browser-based, GPU-accelerated classical quantum circuit simulation software.

  • person
    Ujjwal Roy

    Project lead cited for internal development of EntangleX.

  • person
    Emil Assentato

    CEO cited for the external beta announcement.

Read at source← All news

Related articles

AUG 10
$TWOHMedAI 8/10

UWM Seeks More Than $500M From Two Harbors After Failed Deal

UWM Holdings and UWM Acquisitions 1 LLC sued Two Harbors Investment Corp. in federal court, seeking more than $500 million in damages, alleging breach of contract and fraud tied to the collapse of a $1.3 billion merger. UWM reported a $603.2 million derivatives loss and $451.9 million Q2 net loss after a hedge built for the deal. Two Harbors accepted CrossCountry’s $12 cash offer; CrossCountry agreed to a $25.4 million termination fee.

nationalmortgageprofessional.com6 min
SEP 27
$BABAMedAI 8/10

Is Alibaba (BABA)’s AI Investment Strategy Sustainable?

Alibaba (BABA) unveiled the Zhenwu V900 AI chip, claiming 3x performance improvement over its predecessor. The chip is set for mass production, with commercial availability expected in Q1 2025. Alibaba has invested $53 billion in AI and cloud infrastructure over three years, aiming to expand its cloud data center capacity to 20 gigawatts by 2032.

finance.yahoo.com3 min
SEP 27
$IONQMed

A manufacturing supply chain will be established in Gumi, North Gyeongsang Province, for the first t.. - MK

North Gyeongsang Province, Gumi City, IonQ, and SDT signed a deal to build a 75 billion won quantum system foundry. SDT will produce parts for IonQ's quantum computers, connecting to global supply chains. IonQ, listed on the NYSE, aims to expand manufacturing capabilities. The project addresses Korea's lack of quantum parts production and is part of a broader regional strategy.

mk.co.kr2 min
SEP 27
$MRKMedAI 8/10

How personalised mRNA vaccines are fighting melanoma

Merck and Moderna reported positive Phase 3 trial results for their personalized mRNA vaccine, intismeran autogene (mRNA-4157), combined with pembrolizumab, showing longer recurrence-free survival in high-risk melanoma patients. The vaccine is tailored to each patient's tumor mutations. Detailed data and regulatory review are pending. Accessibility in regions like India may be challenging due to high costs and infrastructure needs.

theweek.in3 min
SEP 27
$MRNALow

Moderna Begins Phase 1 Trial for Bundibugyo Ebola Vaccine

Moderna has started a Phase 1 trial in Canada for its mRNA-1469 vaccine candidate targeting the Bundibugyo strain of Ebola. The trial, supported by CEPI, will enroll 80 people to assess safety and immune response, not efficacy. No results are available yet. This is one of two Bundibugyo-specific vaccine candidates in human testing, with the other developed by the University of Oxford and the Serum Institute of India.

findarticles.com2 min